AlzeCure Pharma
11.10.2021 10:21:54 CEST | ACCESS Newswire | Press release
STOCKHOLM, SE / ACCESSWIRE / October 11, 2021 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6)
AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the central nervous system, with projects in both Alzheimer's disease and pain, today announced that the company is participating at Redeye Neurology (CNS) Seminar on October 13 at 10:55 CEST, where CSO Johan Sandin will present the company's latest developments. The presentation will be followed by a panel discussion together with representatives from AlziNova and BioArctic and moderated by Redeye's analysts.
The presentation will be held in English and live streamed via https://www.redeye.se/events/815803/neurology-seminar-cns-3 . The presentation will also be available afterwards on AlzeCure's website https://www.alzecurepharma.se/en/presentations-and-interviews/ .
For more information, please contact
Martin Jönsson, CEO
Tel: +46 707 86 94 43
martin.jonsson@alzecurepharma.com
About AlzeCure Pharma AB (publ)
AlzeCure® is a Swedish pharmaceutical company that develops new innovative drug therapies for the treatment of severe diseases and conditions that affect the central nervous system, such as Alzheimer's disease and pain - indications for which currently available treatment is very limited. The company is listed on Nasdaq First North Premier Growth Market and is developing several parallel drug candidates based on three research platforms: NeuroRestore®, Alzstatin® and Painless.
NeuroRestore consists of two symptomatic drug candidates where the unique mechanism of action allows for multiple indications, including Alzheimer's disease, as well as cognitive disorders associated with traumatic brain injury, sleep apnea and Parkinson's disease. The Alzstatin platform focuses on developing disease-modifying and preventive drug candidates for early treatment of Alzheimer's disease and comprises two drug candidates. Painless is the company's research platform in the field of pain and contains two projects: ACD440, which is a drug candidate in the clinical development phase for the treatment of neuropathic pain, and TrkA-NAM, which targets severe pain in conditions such as osteoarthritis. AlzeCure aims to pursue its own projects through preclinical research and development to an early clinical phase, and is continually working on business development to find suitable outlicensing solutions with other pharmaceutical companies.
FNCA Sweden AB, +46(0)8 528 00 399 info@fnca.se, is the company's Certified Adviser. For more information, please visit www.alzecurepharma.se.
Image Attachments
Johan Sandin CSO AlzeCure Pharma
Attachments
AlzeCure presents at Redeye Neurology (CNS) Seminar on October 13
SOURCE: AlzeCure Pharma
View source version on accesswire.com:
https://www.accesswire.com/667525/AlzeCure-Presents-at-Redeye-Neurology-CNS-Seminar-on-October-13
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Tenstorrent Unveils TT-QuietBox(TM) 2, the First RISC-V AI Workstation With a Fully Open-Source Stack to Deliver Teraflop-Class Inference11.3.2026 17:00:00 CET | Press release
Liquid-Cooled Desktop System Runs Models up to 120B Parameters Locally With a Fully Open-Source Stack, Starting at $9,999 SANTA CLARA, CA / ACCESS Newswire / March 11, 2026 / Tenstorrent, the AI computing company led by CEO Jim Keller, today announced TT-QuietBox™ 2 (Blackhole™). This whisper-quiet, liquid-cooled AI workstation runs models up to 120 billion parameters directly at your desk, ships with an entirely open-source software stack from compiler to kernel, and starts at $9,999. It marks the industry's first desktop AI workstation built on RISC-V architecture to deliver teraflop-class inference. The Inference Imperative The timing matters. Inference has quietly overtaken training as the dominant AI workload, now accounting for more than 55% of cloud AI infrastructure spending at $37.5 billion - and it is still accelerating. Yet, developers running these workloads face a stark choice: pay per-token cloud fees that compound as usage scales, or buy hardware locked to proprietary st
Clockwork.io Introduces A New Class of Fault Tolerance to End Failure-Driven GPU Waste in AI Training11.3.2026 14:00:00 CET | Press release
New TorchPass solution addresses a multi-million dollar challenge with AI infrastructure; uses Live GPU Migration to keep large-scale AI training running through hardware failures instead of forcing costly restarts PALO ALTO, CA / ACCESS Newswire / March 11, 2026 / Clockwork.io, the leader in Software-Driven AI Fabrics™- a programmable, vendor-neutral software layer that optimizes large-scale GPU clusters for real-time observability, fault tolerance, and deterministic performance-today announced the general availability of TorchPass Workload Fault Tolerance. This new class of software-driven fault-tolerance eliminates one of the most costly failure modes in large-scale AI training: catastrophic job restarts caused by infrastructure faults. Delivered as a core capability of the Clockwork.io FleetIQ™ platform, TorchPass applies the principles of Software-Driven AI Fabrics to distributed training, using Live GPU Migration to allow workloads to continue running through GPU failures, networ
Datavault AI CEO Nathaniel Bradley to Present at Luminary 2026 During Oscars Weekend in Los Angeles11.3.2026 12:00:00 CET | Press release
Datavault AI (Nasdaq:DVLT) Debuts Tokenized Legacy™ Platform and ADIO® Technology at Beverly Center Alongside Scott Page's My Moon Experience, Pink Floyd Live Performance, and Entertainment Industry Luminaries PHILADELPHIA, PA / ACCESS Newswire / March 11, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a provider of data monetization, credentialing, digital engagement, and real‑world asset tokenization technologies, today announced that Chief Executive Officer Nathaniel (Nate) Bradley will deliver a featured presentation at Luminary 2026 - Film, AI, Music and Crypto Innovators, a premier conference taking place Saturday, March 14, 2026, at the Beverly Center (8500 Beverly Blvd, Suite 835, Los Angeles, CA 90048) as part of Oscars Weekend 2026. The Luminary 2026 event is produced by Space Blue/MMF (Dallas Santana) and Hollywood Road Show TV (Chantelle Borelli) and forms the centerpiece of a four-day entertainment and technology activation series running March 1
Context Management Powers Production-Ready AI Analytics at Enterprise Scale11.3.2026 09:00:00 CET | Press release
GoodData delivers governed semantics, grounded knowledge, guided behavior, and full observability for reliable AI analytics. SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / March 11, 2026 / GoodData today introduced Context Management, a governed contextual layer designed to enable production-ready enterprise AI analytics and agents. As organizations deploy AI assistants, copilots, and autonomous agents, they encounter a structural gap: AI lacks enforced business context, governance, and observability. AI pilots demonstrate potential, but moving AI into production exposes the deeper challenge of ensuring answers are consistent, safe, and explainable at scale. Without semantics and traceability, answers shift depending on phrasing. Business rules are applied inconsistently. When outputs change, teams can't explain why. For enterprises, this erodes trust and slows adoption. Many AI analytics platforms rely on prompts, inferred metadata, or loosely integrated document search. Context is sug
Telestream Expands Its Cloud Services with the Introduction of UP11.3.2026 08:05:00 CET | Press release
New cloud-native platform extends Telestream Cloud Services to support Global Ingest, automation, review, and real-time monitoring across hybrid and distributed production environments NEVADA CITY, CA / ACCESS Newswire / March 11, 2026 / Telestream, a global leader in media workflow technologies, today announced the expansion of Telestream Cloud Services with the introduction of UP, a new cloud-native solution designed to support Global Ingest, orchestration, review, and real-time monitoring in modern production environments. With UP, Telestream extends its cloud portfolio beyond high-scale cloud processing and hybrid workflow extension, addressing the growing operational demands of distributed, IP-based media production. As media organizations navigate cost pressures, audience fragmentation, and increasingly distributed production models, cloud adoption has accelerated rapidly but unevenly. Some companies are extending trusted workflows into elastic cloud environments. Others are buil
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom